Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report)’s stock price traded down 0.1% during mid-day trading on Wednesday . The stock traded as low as $10.10 and last traded at $10.11. 13,454 shares traded hands during trading, a decline of 92% from the average session volume of 173,953 shares. The stock had previously closed at $10.12.
Drugs Made in America Acquisition Price Performance
About Drugs Made in America Acquisition
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Featured Stories
- Five stocks we like better than Drugs Made in America Acquisition
- Transportation Stocks Investing
- 2 Stocks Riding the Dominance of America’s Natural Gas Exports
- How to Plot Fibonacci Price Inflection Levels
- Buffett’s on the Sidelines – Should You Follow?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
